(1)
Surgical Approach With Vascular Reconstruction After an Objective Response to Neoadjuvant Therapy With an EGFR Tyrosine Kinase Inhibitor: Clinical Case. Вопр. онкол. 2022, 67 (2), 278-281. https://doi.org/10.37469/0507-3758-2021-67-2-278-281.